Liu M, Wang Y, Zhang Y, Hu D, Tang L, Zhou B
Signal Transduct Target Ther. 2025; 10(1):73.
PMID: 40059188
PMC: 11891339.
DOI: 10.1038/s41392-024-02112-8.
Liu Z, Liu Y, Kang X, Li L, Xiang Y
Pharmaceutics. 2025; 17(2).
PMID: 40006565
PMC: 11859411.
DOI: 10.3390/pharmaceutics17020198.
Kuang L, Wu L, Li Y
Mol Cancer. 2025; 24(1):45.
PMID: 39953480
PMC: 11829561.
DOI: 10.1186/s12943-025-02233-w.
Moreno-Vargas L, Prada-Gracia D
Int J Mol Sci. 2025; 26(1.
PMID: 39795918
PMC: 11720145.
DOI: 10.3390/ijms26010059.
Moreno-Vargas L, Prada-Gracia D
Int J Mol Sci. 2025; 26(1.
PMID: 39795861
PMC: 11720565.
DOI: 10.3390/ijms26010002.
Synthesis and Characterization of Transferrin and Cell-Penetrating Peptide-Functionalized Liposomal Nanoparticles to Deliver Plasmid ApoE2 and in Mice.
Muolokwu C, Gothwal A, Kanekiyo T, Singh J
Mol Pharm. 2024; 22(1):229-241.
PMID: 39665408
PMC: 11888121.
DOI: 10.1021/acs.molpharmaceut.4c00870.
Conjugated therapeutic proteins as a treatment for bacteria which trigger cancer development.
Halawa M, Newman P, Aderibigbe T, Carabetta V
iScience. 2024; 27(10):111029.
PMID: 39635133
PMC: 11615139.
DOI: 10.1016/j.isci.2024.111029.
Cell-penetrating peptides TAT and 8R functionalize P22 virus-like particles to enhance tissue distribution and retention .
Su S, Shen X, Shi X, Li X, Chen J, Yang W
Front Vet Sci. 2024; 11:1460973.
PMID: 39290505
PMC: 11405305.
DOI: 10.3389/fvets.2024.1460973.
MeCP2 is a naturally supercharged protein with cell membrane transduction capabilities.
Beribisky A, Huber A, Sarne V, Spittler A, Sukhbaatar N, Seipel T
Protein Sci. 2024; 33(10):e5170.
PMID: 39276009
PMC: 11400631.
DOI: 10.1002/pro.5170.
Glycooligomer-Functionalized Catalytic Nanocompartments Co-Loaded with Enzymes Support Parallel Reactions and Promote Cell Internalization.
Korpidou M, Becker J, Tarvirdipour S, Dinu I, Becer C, Palivan C
Biomacromolecules. 2024; 25(7):4492-4509.
PMID: 38910355
PMC: 11238334.
DOI: 10.1021/acs.biomac.4c00526.
Potential of Cell-Penetrating Peptide-Conjugated Antisense Oligonucleotides for the Treatment of SMA.
Leckie J, Yokota T
Molecules. 2024; 29(11).
PMID: 38893532
PMC: 11173757.
DOI: 10.3390/molecules29112658.
POSEIDON: Peptidic Objects SEquence-based Interaction with cellular DOmaiNs: a new database and predictor.
Preto A, Caniceiro A, Duarte F, Fernandes H, Ferreira L, Mourao J
J Cheminform. 2024; 16(1):18.
PMID: 38365724
PMC: 10874016.
DOI: 10.1186/s13321-024-00810-7.
Role of cell membrane homeostasis in the pathogenicity of pathogenic filamentous fungi.
Peng Y, Chen B
Virulence. 2023; 15(1):2299183.
PMID: 38156783
PMC: 10761126.
DOI: 10.1080/21505594.2023.2299183.
Polyarginine Cell-Penetrating Peptides Bind and Inhibit SERCA2.
Lunde P, Manfra O, Stole T, Lunde M, Martinsen M, Carlson C
Cells. 2023; 12(19).
PMID: 37830576
PMC: 10571751.
DOI: 10.3390/cells12192358.
Affinity membrane adsorbers for binding arginine-rich proteins.
Chenette H, Welsh J, Husson S
Sep Sci Technol. 2023; 52(2):276-286.
PMID: 37830059
PMC: 10569433.
DOI: 10.1080/01496395.2016.1206934.
A Nucleus-Targeting WT1 Antagonistic Peptide Encapsulated in Polymeric Nanomicelles Combats Refractory Chronic Myeloid Leukemia.
Chen M, Fang X, Du R, Meng J, Liu J, Liu M
Pharmaceutics. 2023; 15(9).
PMID: 37765274
PMC: 10534672.
DOI: 10.3390/pharmaceutics15092305.
Designing Cell-Permeable Peptide Therapeutics That Enter the Cell by Endocytosis.
Pei D
ACS Symp Ser Am Chem Soc. 2023; 1417:179-197.
PMID: 37621949
PMC: 10448808.
DOI: 10.1021/bk-2022-1417.ch007.
Engineered phage with cell-penetrating peptides for intracellular bacterial infections.
Zhao M, Tan X, Liu Z, Dou L, Liu D, Pan Y
mSystems. 2023; 8(5):e0064623.
PMID: 37594262
PMC: 10654057.
DOI: 10.1128/msystems.00646-23.
Development of a peptide drug restoring AMPK and adipose tissue functionality in cancer cachexia.
Ji H, Englmaier F, Morigny P, Giroud M, Grasle P, Brings S
Mol Ther. 2023; 31(8):2408-2421.
PMID: 37408309
PMC: 10422018.
DOI: 10.1016/j.ymthe.2023.06.020.
Adjusting Heterodimeric Coiled-Coils (K/E Zipper) to Connect Autophagy-Inducing Peptide with Cell-Penetrating Peptide.
Hakata Y, Yamashita K, Hashimoto S, Ohtsuki T, Miyazawa M, Kitamatsu M
Pharmaceutics. 2023; 15(4).
PMID: 37111533
PMC: 10141234.
DOI: 10.3390/pharmaceutics15041048.